FDA Adverse Event Malfunction Summary report: N

4 LESION NT2000¿ PAIN MANAGEMENT RF GENERATOR

MDR report key: 9918061 · Received April 2, 2020

Report

Report Number
3002953813-2020-00015
Event Type
Malfunction
Date Received
April 2, 2020
Date of Event
March 16, 2020
Report Date
May 26, 2020
Manufacturer
NEUROTHERM, INC
Product Code
GXD
UDI-DI
05415067022417
PMA / PMN Number
K111576
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

CORRECTED INFORMATION: H6. ADDITIONAL INFORMATION: G4, G7, H2.

Additional Manufacturer Narrative · 0

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

Additional Manufacturer Narrative · 1

THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN A SUBSEQUENT SUBMISSION.

Description of Event or Problem · 1

DURING A RADIOFREQUENCY (RF) ABLATION PROCEDURE, THE RF GENERATOR RELEASED RF THERAPY WITHOUT BEING SELECTED. AFTER PLACING THE PROBE IN THE TREATMENT LOCATION, THE USER CHANGED THE GENERATOR SETTINGS FROM SENSORY TESTING TO PULSED RF. RF ENERGY WAS DELIVERED, HOWEVER; THE PATIENT WAS STARTLED AS THE RF WAS NOT EXPECTED. THE PROBE WAS DISCONNECTED FROM THE GENERATOR AND THE GENERATOR WAS STOPPED WHEN THIS OCCURRED TO PREVENT ANY FURTHER DELIVERY OF RF ENERGY. AN ERROR MESSAGE WAS DISPLAYED AT THIS TIME AS WELL. THE PATIENT REMAINED STABLE THROUGHOUT THE DURATION OF THE PROCEDURE AND THE PROCEDURE WAS CONTINUED AND COMPLETED. THERE WERE NO ADVERSE PATIENT CONSEQUENCES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
382061 4 LESION NT2000¿ PAIN MANAGEMENT RF GENERATOR GENERATOR, LESION, RADIOFREQUENCY GXD NEUROTHERM, INC RFG-NT-2000 9800229 05415067022417

Patients

Seq Age Sex Outcome Treatment
1